Definity Financial (TSE:DFY – Free Report) had its price target lifted by Raymond James from C$65.00 to C$74.00 in a research report sent to investors on Thursday,BayStreet.CA reports. They currently have a market perform rating on the stock. Raymond James also issued estimates for Definity Financial’s Q2 2025 earnings at $0.76 EPS, Q3 2025 earnings at $0.74 EPS, Q4 2025 earnings at $0.96 EPS, FY2025 earnings at $3.12 EPS and Q1 2026 earnings at $0.81 EPS.
DFY has been the subject of a number of other research reports. TD Securities upped their price objective on Definity Financial from C$72.00 to C$78.00 and gave the company a “hold” rating in a research note on Wednesday. Scotiabank raised their price objective on shares of Definity Financial from C$65.00 to C$76.00 in a report on Wednesday. BMO Capital Markets lifted their price objective on shares of Definity Financial from C$63.00 to C$64.00 in a research report on Monday, May 12th. UBS Group increased their target price on shares of Definity Financial from C$58.00 to C$63.00 in a research report on Tuesday, February 18th. Finally, Desjardins upgraded shares of Definity Financial to a “hold” rating in a research note on Wednesday. Six equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of C$69.27.
Check Out Our Latest Report on Definity Financial
Definity Financial Trading Up 1.6%
Definity Financial Company Profile
Definity Financial Corp is a multi-channel, property, and casualty insurance company. It offers auto, property, liability, and pet insurance products to individual customers.
Featured Articles
- Five stocks we like better than Definity Financial
- How to Short Nasdaq: An Easy-to-Follow Guide
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Why Are Stock Sectors Important to Successful Investing?
- 3 Stocks Set to Double—And There’s Still Time to Buy
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Definity Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definity Financial and related companies with MarketBeat.com's FREE daily email newsletter.